What is KLOW?
KLOW is an advanced research peptide formulation that combines four synergistic compounds: TB-500 (10 mg), BPC-157 (10 mg), GHK-Cu (50 mg), and KPV (10 mg). This blend is supplied in a single 80 mg vial of lyophilised powder and is designed for in vitro research into cellular modulation, inflammatory pathways, and peptide-based signalling mechanisms. Every batch is manufactured to research-grade standards with ≥98% HPLC-verified purity.
Research Applications
- Analysis of multi-peptide receptor interactions
- Investigations into cellular signalling pathways
- Studies involving copper peptide (GHK-Cu) mechanisms
- Exploration of KPV in inflammation modulation research
Key Features
- 4-in-1 research peptide formulation
- Total content: 80 mg lyophilised powder
- Includes TB-500, BPC-157, GHK-Cu, and KPV
- ≥98% purity (HPLC verified)
- Batch-specific Certificate of Analysis (COA) available
Specifications
| Product Name | KLOW Peptide Blend |
|---|---|
| Total Peptide Content | 80 mg |
| Breakdown | TB-500 (10 mg), BPC-157 (10 mg), GHK-Cu (50 mg), KPV (10 mg) |
| Form | Lyophilised powder |
| Purity | ≥98% (HPLC) |
| Appearance | White to off-white powder |
| Solubility | Soluble in sterile bacteriostatic water |
| Storage (unopened) | –20 °C (recommended; protect from light) |
| Storage (after reconstitution) | 2–8 °C; aliquoting recommended to maintain stability |
| Documentation | Certificate of Analysis available |
Reconstitution & Handling
- Reconstitute using bacteriostatic water or a suitable research solvent
- Gently swirl until dissolved; avoid excessive agitation
- Aliquot if storing reconstituted peptide to avoid freeze thaw degradation
Quality & Testing
All KLOW peptide vials undergo high-performance liquid chromatography (HPLC) testing and mass spectrometry analysis to confirm purity and identity. COAs are batch-specific and available upon request.
Important Notice
For laboratory research use only. Not for human consumption, medical use, or diagnostic procedures.
Reviews
There are no reviews yet.